Roche gets emergency approval for combination flu, COVID-19 test

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.

Maia Anderson –
Friday, September 4th, 2020
Print|Email.

Roche said it plans to deliver “as lots of tests as possible within the limitations of supply.”.

Check out the complete news release here..

” With the approaching influenza season, this brand-new test is especially crucial as SARS-CoV-2 and influenza infections can hardly be differentiated by signs alone,” stated Roche Diagnostics CEO Thomas Schinecker. “Now, with a single test, health care specialists can with confidence offer the ideal medical diagnosis and most reliable treatment prepare for their clients.”.

The test utilizes a single sample to distinguish between COVID-19 and the influenza. Roche said the test makers can supply outcomes for 96 tests in three hours..

More articles on supply chain: NIH offers $129M to 9 business to improve COVID-19 testingHHS to provide Abbotts quick COVID-19 tests to states this month10 medical facilities looking for supply chain talent.

Roche said Sept. 4 it has received emergency authorization from the FDA for its nasal swab test that finds the influenza and COVID-19 and differentiates between the two viruses..